Impact of Ureteral Stent and Sheaths Size on Post-Operative Pain
NCT ID: NCT06979583
Last Updated: 2025-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
100 participants
INTERVENTIONAL
2025-11-30
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Postoperative Pain After Ureterorenoscopy.
NCT07283003
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
NCT07223580
Differences in Postoperative Symptoms With Four Ureteral Stents
NCT06083051
Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial
NCT03855787
Evaluation of Ureteral Stents in the Management of Stone Disease
NCT02211313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: 4.8 Fr Ureteral stents
4.8 Fr Ureteral stents
After surgery, patients will have the Boston Scientific 4.8 Fr ureteral stent placed.
Group B: 7 Fr Ureteral stents
7 Fr Ureteral stents
After surgery, patients will have the Bard 7 Fr ureteral stent placed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
4.8 Fr Ureteral stents
After surgery, patients will have the Boston Scientific 4.8 Fr ureteral stent placed.
7 Fr Ureteral stents
After surgery, patients will have the Bard 7 Fr ureteral stent placed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient undergoing ureteroscopy for any indication other than stone extraction.
* Patients who are currently pregnant as determined by clinical presurgical screening.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meghan A. Cooper
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meghan A. Cooper, DO
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-009000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.